Fig. 2

Representative images of mucositis induced by target therapies. (a-b) patchy ulcerations (aphtous ulcerations) induced by cetuximab, (c) erythema of the mucosa induced by temsirolimus and (d) ulcerations bleeding with minor trauma induced by everolimus